|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
KETOROLAC TROMETHAMINE (OPHTHALMIC SOLUTION)
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
Conjunctivitis, allergic |
|
Inflammation, ophthalmic |
|
Pain, ophthalmic |
|
Photophobia, postoperative |
|
Pruritus, ocular |
| |
|
|
SIDE EFFECTS:
|
|
Hypersensitivity |
|
keratitis, superficial |
|
ocular irritation |
|
Stinging or burning upon instillation of medication |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
Hemophiliading problems |
|
Prolonged bleeding time |
|
|
ADULT DOSE:
|
|
Conjunctivitis, allergic (treatment) -
Topical, to the conjunctiva, 1 drop in each eye four times a day.
Inflammation, ocular (treatment)-
In the U.S.: Topical, to the conjunctiva, 1 drop in the affected eye(s) four times a day beginning twenty-four hours after cataract surgery and continuing for two weeks.
[Inflammation, ocular (prophylaxis and treatment)]-
In Canada: Topical, to the conjunctiva, 1 drop in each eye every six to eight hours beginning twenty-four hours before surgery and continuing for three to four weeks. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Safety and efficacy have not been established.
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|